[go: up one dir, main page]

NI200900078A - Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización. - Google Patents

Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización.

Info

Publication number
NI200900078A
NI200900078A NI200900078A NI200900078A NI200900078A NI 200900078 A NI200900078 A NI 200900078A NI 200900078 A NI200900078 A NI 200900078A NI 200900078 A NI200900078 A NI 200900078A NI 200900078 A NI200900078 A NI 200900078A
Authority
NI
Nicaragua
Prior art keywords
compositions containing
manufacturing
substituted pyrazoles
use procedure
pyrazoles
Prior art date
Application number
NI200900078A
Other languages
English (en)
Inventor
Bjergarde Kirsten
Dodson Mark
Mauger Jacques
Nair Anil
Patek Marcel
Tabart Michel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NI200900078A publication Critical patent/NI200900078A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se refiere principalmente a compuestos químicos nuevos, particularmente a pirazoles sustituidos, a las composiciones que los contienen, y a su utilización como medicamentos.
NI200900078A 2006-11-10 2009-05-06 Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización. NI200900078A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0609812A FR2908409B1 (fr) 2006-11-10 2006-11-10 Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
NI200900078A true NI200900078A (es) 2010-01-27

Family

ID=38169388

Family Applications (1)

Application Number Title Priority Date Filing Date
NI200900078A NI200900078A (es) 2006-11-10 2009-05-06 Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización.

Country Status (39)

Country Link
US (3) US7989439B2 (es)
EP (1) EP2091920B1 (es)
JP (1) JP5538893B2 (es)
KR (1) KR20090083456A (es)
CN (1) CN101553473B (es)
AR (1) AR063638A1 (es)
AU (1) AU2007327423B2 (es)
BR (1) BRPI0718999A2 (es)
CA (1) CA2667846A1 (es)
CL (1) CL2007003251A1 (es)
CO (1) CO6190516A2 (es)
CR (1) CR10749A (es)
CY (1) CY1116000T1 (es)
DK (1) DK2091920T3 (es)
DO (1) DOP2009000088A (es)
EA (1) EA019454B1 (es)
EC (1) ECSP099312A (es)
ES (1) ES2528385T3 (es)
FR (1) FR2908409B1 (es)
HN (1) HN2009000856A (es)
HR (1) HRP20150070T1 (es)
IL (1) IL198328A0 (es)
MA (1) MA30972B1 (es)
MX (1) MX2009004983A (es)
MY (1) MY147502A (es)
NI (1) NI200900078A (es)
NO (1) NO20091990L (es)
NZ (1) NZ576709A (es)
PE (2) PE20081162A1 (es)
PL (1) PL2091920T3 (es)
PT (1) PT2091920E (es)
SI (1) SI2091920T1 (es)
SV (1) SV2009003253A (es)
TN (1) TN2009000155A1 (es)
TW (1) TW200829556A (es)
UA (1) UA97965C2 (es)
UY (1) UY30707A1 (es)
WO (1) WO2008065282A2 (es)
ZA (1) ZA200903560B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858323B2 (en) * 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique
AR079967A1 (es) * 2010-01-26 2012-02-29 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos con oxigeno y su uso como productos farmaceuticos
TWI523844B (zh) * 2011-01-26 2016-03-01 賽諾菲公司 經胺基取代之３－雜芳醯基胺基－丙酸衍生物及其作為藥物之用途
CN102432639B (zh) * 2011-09-30 2013-11-06 山东大学 1-(2-羟基-3-(苯氨基)丙基)-3-二茂铁基-1h-吡唑-5-甲酸乙酯化合物及其应用
WO2014068527A1 (en) 2012-11-02 2014-05-08 Pfizer Inc. Bruton's tyrosine kinase inhibitors
RU2017134379A (ru) 2015-03-25 2019-04-03 Новартис Аг Формилированные n-гетероциклические производные в качестве ингибиторов fgfr4
CN107619388A (zh) * 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878714B2 (en) * 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
WO2002088090A2 (en) * 2001-04-27 2002-11-07 Vertex Pharmaceuticals Incorporated Pyrazole derived kinase inhibitors
KR20060003351A (ko) * 2003-04-16 2006-01-10 아스트라제네카 아베 화합물
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
CA2532965C (en) * 2003-07-22 2013-05-14 Astex Therapeutics Limited 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
JP2008505167A (ja) * 2004-07-05 2008-02-21 アステックス、セラピューティックス、リミテッド 医薬組成物
WO2006018662A2 (en) * 2004-08-16 2006-02-23 Prosidion Limited Aryl urea derivatives for treating obesity
US20100160324A1 (en) * 2004-12-30 2010-06-24 Astex Therapeutics Limited Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
US20080161355A1 (en) * 2005-01-21 2008-07-03 Astex Therapeutics Limited Combinations of Pyrazole Kinase Inhibitors and Further Antitumor Agents
AR052559A1 (es) * 2005-01-21 2007-03-21 Astex Therapeutics Ltd Derivados de pirazol para inhibir cdk's y gsk's
EP1683796A1 (en) * 2005-01-24 2006-07-26 Schering Aktiengesellschaft Pyrazolopyridines, their preparation and their medical use
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
SV2009003253A (es) 2009-10-27
SI2091920T1 (sl) 2015-02-27
AR063638A1 (es) 2009-02-04
UA97965C2 (ru) 2012-04-10
PT2091920E (pt) 2015-02-05
CA2667846A1 (fr) 2008-06-05
US20110237801A1 (en) 2011-09-29
EA019454B1 (ru) 2014-03-31
JP5538893B2 (ja) 2014-07-02
PE20081162A1 (es) 2008-10-02
IL198328A0 (en) 2010-02-17
MY147502A (en) 2012-12-14
AU2007327423B2 (en) 2012-09-06
TN2009000155A1 (fr) 2010-10-18
ES2528385T3 (es) 2015-02-09
HK1137988A1 (en) 2010-08-13
PE20121152A1 (es) 2012-09-07
EP2091920A2 (fr) 2009-08-26
AU2007327423A1 (en) 2008-06-05
US20110237641A1 (en) 2011-09-29
FR2908409B1 (fr) 2009-01-09
WO2008065282A3 (fr) 2008-07-31
EP2091920B1 (fr) 2014-10-22
WO2008065282A2 (fr) 2008-06-05
CY1116000T1 (el) 2017-01-25
ECSP099312A (es) 2009-06-30
CR10749A (es) 2009-07-23
MA30972B1 (fr) 2009-12-01
CN101553473B (zh) 2013-06-05
HRP20150070T1 (hr) 2015-02-27
CN101553473A (zh) 2009-10-07
US7989439B2 (en) 2011-08-02
JP2010509297A (ja) 2010-03-25
FR2908409A1 (fr) 2008-05-16
US8420824B2 (en) 2013-04-16
BRPI0718999A2 (pt) 2014-02-25
US20090291984A1 (en) 2009-11-26
CO6190516A2 (es) 2010-08-19
TW200829556A (en) 2008-07-16
ZA200903560B (en) 2010-08-25
DK2091920T3 (en) 2015-01-26
CL2007003251A1 (es) 2009-08-07
MX2009004983A (es) 2009-05-22
PL2091920T3 (pl) 2015-04-30
NZ576709A (en) 2011-08-26
DOP2009000088A (es) 2013-06-15
HN2009000856A (es) 2011-10-19
UY30707A1 (es) 2008-07-03
NO20091990L (no) 2009-06-02
KR20090083456A (ko) 2009-08-03
EA200970472A1 (ru) 2009-10-30
US8410286B2 (en) 2013-04-02

Similar Documents

Publication Publication Date Title
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
NI200900078A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización.
HN2003000094A (es) Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
HN2006018410A (es) Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion
CR9463A (es) Pirrolinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
CR20110309A (es) Compuestos orgánicos
ECSP11011184A (es) Compuestos orgánicos
ECSP088932A (es) Nuevos compuestos químicos
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
CU23840B1 (es) Nuevos derivados de sulfonamida como antagonistas de la bradiquinina
CR20110288A (es) N-oxiamidas espiroheterocíclicas como pesticidas
BRPI0518758A2 (pt) compostos de acetamida como fungicidas
UY31260A1 (es) Compuestos de pirazol, composiciones conteniendolos y aplicaciones.
ECSP066373A (es) Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
UY31688A1 (es) Plaguicidas
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
UY28350A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilización
ECSP099791A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparación y su aplicación en terapéutica
SV2010003501A (es) Fungicidas novedosos
UY29486A1 (es) Compuestos utiles en terapia
UY32101A (es) Compuestos de triazol, su uso, así como productos que los contienen
CR9231A (es) Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion
UY29361A1 (es) Pirroles e imidazoles sustituídos, composiciones que los contienen, procedimiento de fabricación y utilización